1. Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, et al. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 2: biodistribution and brain imaging in humans. J Nucl Med. 1989;30:1902–10.
2. Walovitch RC, Hill TC, Garrity ST, Cheesman EH, Burgess BA, O’Leary DH, et al. Characterization of technetium-99m-L, L-ECD for brain perfusion imaging, Part 1: pharmacology of technetium-99m ECD in nonhuman primates. J Nucl Med. 1989;30:1892–901.
3. Vallabhajosula S, Zimmerman RE, Picard M, Stritzke P, Mena I, Hellman RS, et al. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med. 1989;30:599–604.
4. Sharp PF, Smith FW, Gemmell HG, Lyall D, Evans NT, Gvozdanovic D, et al. Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies. J Nucl Med. 1986;27:171–7.
5. Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, et al. Technetium-99m d, l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med. 1987;28:191–202.